(EOG) EOG Resources - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US26875P1012
Stock: Crude Oil, Natural Gas, Natural Gas Liquids, Condensate
Total Rating 39
Risk 28
Buy Signal 0.66
| Risk 5d forecast | |
|---|---|
| Volatility | 28.1% |
| Relative Tail Risk | -1.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.18 |
| Alpha | -10.25 |
| Character TTM | |
|---|---|
| Beta | 0.569 |
| Beta Downside | 1.504 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.72% |
| CAGR/Max DD | 0.26 |
EPS (Earnings per Share)
Revenue
Description: EOG EOG Resources March 03, 2026
EOG Resources Inc. (NYSE: EOG) is an integrated upstream company that explores, develops, produces and markets crude oil, natural-gas liquids and natural gas across U.S. basins, Trinidad & Tobago, and other international locations. Its operations also include gathering, processing and marketing of crude oil and condensate.
In the latest quarter (Q4 2025), EOG delivered 1.12 million barrels of oil-equivalent per day of net production, generated $2.1 billion of operating cash flow, and reported adjusted earnings of $3.45 per share, supporting a quarterly dividend of $0.71 per share (≈ 2.5% yield).
Key drivers for the business remain the U.S. shale cost advantage, the spread between Henry Hub natural-gas prices and oil prices, and OPEC+ output policies that continue to underpin crude-price stability. Additionally, the company’s disciplined capital allocation and focus on high-return assets position it to benefit from any upside in the energy price environment.
For a deeper dive into EOG’s valuation and risk profile, you might explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 4.98b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -5.35 > 1.0 |
| NWC/Revenue: 15.02% < 20% (prev 25.13%; Δ -10.12% < -1%) |
| CFO/TA 0.19 > 3% & CFO 10.04b > Net Income 4.98b |
| Net Debt (5.01b) to EBITDA (11.30b): 0.44 < 3 |
| Current Ratio: 1.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (539.2m) vs 12m ago -3.88% < -2% |
| Gross Margin: 68.11% > 18% (prev 0.76%; Δ 6735 % > 0.5%) |
| Asset Turnover: 45.60% > 50% (prev 49.54%; Δ -3.95% > 0%) |
| Interest Coverage Ratio: 29.82 > 6 (EBITDA TTM 11.30b / Interest Expense TTM 220.0m) |
Altman Z'' 4.63
| A: 0.07 (Total Current Assets 7.09b - Total Current Liabilities 3.70b) / Total Assets 51.80b |
| B: 0.57 (Retained Earnings 29.77b / Total Assets 51.80b) |
| C: 0.13 (EBIT TTM 6.56b / Avg Total Assets 49.49b) |
| D: 1.36 (Book Value of Equity 29.96b / Total Liabilities 21.97b) |
| Altman-Z'' Score: 4.63 = AA |
Beneish M 1.00
| DSRI: 1.05 (Receivables 2.68b/2.65b, Revenue 22.57b/23.38b) |
| GMI: 1.11 (GM 68.11% / 75.70%) |
| AQI: 19.78 (AQ_t 0.73 / AQ_t-1 0.04) |
| SGI: 0.97 (Revenue 22.57b / 23.38b) |
| TATA: -0.10 (NI 4.98b - CFO 10.04b) / TA 51.80b) |
| Beneish M-Score: 8.13 (Cap -4..+1) = D |
What is the price of EOG shares?
As of March 03, 2026, the stock is trading at USD 128.65 with a total of 9,085,637 shares traded.
Over the past week, the price has changed by +5.18%, over one month by +18.67%, over three months by +19.09% and over the past year by +10.68%.
Over the past week, the price has changed by +5.18%, over one month by +18.67%, over three months by +19.09% and over the past year by +10.68%.
Is EOG a buy, sell or hold?
EOG Resources has received a consensus analysts rating of 3.97.
Therefore, it is recommended to buy EOG.
- StrongBuy: 13
- Buy: 6
- Hold: 14
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EOG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 132.9 | 3.3% |
| Analysts Target Price | 132.9 | 3.3% |
EOG Fundamental Data Overview March 02, 2026
P/E Trailing = 13.6053
P/E Forward = 12.0337
P/S = 2.9719
P/B = 2.2314
P/EG = 2.7666
Revenue TTM = 22.57b USD
EBIT TTM = 6.56b USD
EBITDA TTM = 11.30b USD
Long Term Debt = 7.82b USD (from longTermDebt, last quarter)
Short Term Debt = 499.0m USD (from shortTermDebt, last quarter)
Debt = 8.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.01b USD (from netDebt column, last quarter)
Enterprise Value = 72.34b USD (67.33b + Debt 8.41b - CCE 3.40b)
Interest Coverage Ratio = 29.82 (Ebit TTM 6.56b / Interest Expense TTM 220.0m)
EV/FCF = 20.31x (Enterprise Value 72.34b / FCF TTM 3.56b)
FCF Yield = 4.92% (FCF TTM 3.56b / Enterprise Value 72.34b)
FCF Margin = 15.78% (FCF TTM 3.56b / Revenue TTM 22.57b)
Net Margin = 22.07% (Net Income TTM 4.98b / Revenue TTM 22.57b)
Gross Margin = 68.11% ((Revenue TTM 22.57b - Cost of Revenue TTM 7.20b) / Revenue TTM)
Gross Margin QoQ = 77.78% (prev 61.85%)
Tobins Q-Ratio = 1.40 (Enterprise Value 72.34b / Total Assets 51.80b)
Interest Expense / Debt = 0.61% (Interest Expense 51.0m / Debt 8.41b)
Taxrate = 21.00% (186.3m / 887.3m)
NOPAT = 5.18b (EBIT 6.56b * (1 - 21.00%))
Current Ratio = 1.92 (Total Current Assets 7.09b / Total Current Liabilities 3.70b)
Debt / Equity = 0.28 (Debt 8.41b / totalStockholderEquity, last quarter 29.83b)
Debt / EBITDA = 0.44 (Net Debt 5.01b / EBITDA 11.30b)
Debt / FCF = 1.41 (Net Debt 5.01b / FCF TTM 3.56b)
Total Stockholder Equity = 29.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.06% (Net Income 4.98b / Total Assets 51.80b)
RoE = 16.76% (Net Income TTM 4.98b / Total Stockholder Equity 29.72b)
RoCE = 17.47% (EBIT 6.56b / Capital Employed (Equity 29.72b + L.T.Debt 7.82b))
RoIC = 14.46% (NOPAT 5.18b / Invested Capital 35.84b)
WACC = 7.17% (E(67.33b)/V(75.73b) * Re(8.01%) + D(8.41b)/V(75.73b) * Rd(0.61%) * (1-Tc(0.21)))
Discount Rate = 8.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.66%
[DCF] Terminal Value 80.17% ; FCFF base≈4.45b ; Y1≈4.12b ; Y5≈3.74b
[DCF] Fair Price = 138.7 (EV 79.40b - Net Debt 5.01b = Equity 74.39b / Shares 536.5m; r=7.17% [WACC]; 5y FCF grow -9.32% → 2.90% )
EPS Correlation: -64.29 | EPS CAGR: -14.02% | SUE: 0.65 | # QB: 0
Revenue Correlation: -12.69 | Revenue CAGR: 9.71% | SUE: 0.51 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.20 | Chg7d=-0.047 | Chg30d=-0.029 | Revisions Net=-5 | Analysts=25
EPS current Year (2026-12-31): EPS=9.48 | Chg7d=-0.171 | Chg30d=-0.104 | Revisions Net=-8 | Growth EPS=-6.7% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=11.11 | Chg7d=-0.031 | Chg30d=-0.295 | Revisions Net=-6 | Growth EPS=+17.3% | Growth Revenue=+4.6%
[Analyst] Revisions Ratio: -0.38 (4 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.7% (Discount Rate 8.0% - Earnings Yield 7.4%)
[Growth] Growth Spread = +2.8% (Analyst 3.5% - Implied 0.7%)
P/E Forward = 12.0337
P/S = 2.9719
P/B = 2.2314
P/EG = 2.7666
Revenue TTM = 22.57b USD
EBIT TTM = 6.56b USD
EBITDA TTM = 11.30b USD
Long Term Debt = 7.82b USD (from longTermDebt, last quarter)
Short Term Debt = 499.0m USD (from shortTermDebt, last quarter)
Debt = 8.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.01b USD (from netDebt column, last quarter)
Enterprise Value = 72.34b USD (67.33b + Debt 8.41b - CCE 3.40b)
Interest Coverage Ratio = 29.82 (Ebit TTM 6.56b / Interest Expense TTM 220.0m)
EV/FCF = 20.31x (Enterprise Value 72.34b / FCF TTM 3.56b)
FCF Yield = 4.92% (FCF TTM 3.56b / Enterprise Value 72.34b)
FCF Margin = 15.78% (FCF TTM 3.56b / Revenue TTM 22.57b)
Net Margin = 22.07% (Net Income TTM 4.98b / Revenue TTM 22.57b)
Gross Margin = 68.11% ((Revenue TTM 22.57b - Cost of Revenue TTM 7.20b) / Revenue TTM)
Gross Margin QoQ = 77.78% (prev 61.85%)
Tobins Q-Ratio = 1.40 (Enterprise Value 72.34b / Total Assets 51.80b)
Interest Expense / Debt = 0.61% (Interest Expense 51.0m / Debt 8.41b)
Taxrate = 21.00% (186.3m / 887.3m)
NOPAT = 5.18b (EBIT 6.56b * (1 - 21.00%))
Current Ratio = 1.92 (Total Current Assets 7.09b / Total Current Liabilities 3.70b)
Debt / Equity = 0.28 (Debt 8.41b / totalStockholderEquity, last quarter 29.83b)
Debt / EBITDA = 0.44 (Net Debt 5.01b / EBITDA 11.30b)
Debt / FCF = 1.41 (Net Debt 5.01b / FCF TTM 3.56b)
Total Stockholder Equity = 29.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.06% (Net Income 4.98b / Total Assets 51.80b)
RoE = 16.76% (Net Income TTM 4.98b / Total Stockholder Equity 29.72b)
RoCE = 17.47% (EBIT 6.56b / Capital Employed (Equity 29.72b + L.T.Debt 7.82b))
RoIC = 14.46% (NOPAT 5.18b / Invested Capital 35.84b)
WACC = 7.17% (E(67.33b)/V(75.73b) * Re(8.01%) + D(8.41b)/V(75.73b) * Rd(0.61%) * (1-Tc(0.21)))
Discount Rate = 8.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.66%
[DCF] Terminal Value 80.17% ; FCFF base≈4.45b ; Y1≈4.12b ; Y5≈3.74b
[DCF] Fair Price = 138.7 (EV 79.40b - Net Debt 5.01b = Equity 74.39b / Shares 536.5m; r=7.17% [WACC]; 5y FCF grow -9.32% → 2.90% )
EPS Correlation: -64.29 | EPS CAGR: -14.02% | SUE: 0.65 | # QB: 0
Revenue Correlation: -12.69 | Revenue CAGR: 9.71% | SUE: 0.51 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.20 | Chg7d=-0.047 | Chg30d=-0.029 | Revisions Net=-5 | Analysts=25
EPS current Year (2026-12-31): EPS=9.48 | Chg7d=-0.171 | Chg30d=-0.104 | Revisions Net=-8 | Growth EPS=-6.7% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=11.11 | Chg7d=-0.031 | Chg30d=-0.295 | Revisions Net=-6 | Growth EPS=+17.3% | Growth Revenue=+4.6%
[Analyst] Revisions Ratio: -0.38 (4 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.7% (Discount Rate 8.0% - Earnings Yield 7.4%)
[Growth] Growth Spread = +2.8% (Analyst 3.5% - Implied 0.7%)